Susquehanna Trust & Investment’s Pfizer PFE Stock Holding History

Susquehanna Trust & Investment’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$12.6M	Sell	395,313 -16,472	-4%	-$537K	2.75%	2
2015 Q1	$13.6M	Sell	411,785 -12,015	-3%	-$382K	2.87%	2
2014 Q4	$12.5M	Sell	423,800 -15,518	-4%	-$445K	2.55%	6
2014 Q3	$12.3M	Sell	439,318 -31,921	-7%	-$896K	2.67%	5
2014 Q2	$13.3M	Sell	471,239 -16,215	-3%	-$462K	2.82%	5
2014 Q1	$14.9M	Buy	487,454 +1,542	+0.3%	+$46K	3.29%	1
2013 Q4	$14.1M	Sell	485,912 -90,595	-16%	-$2.64M	3.04%	3
2013 Q3	$15.7M	Sell	576,507 -8,140	-1%	-$221K	3.44%	1
2013 Q2	$15.5M	Buy	+584,647	New	+$16.2M	3.65%	2

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Susquehanna Trust & Investment's PFE Position: Q2 2015 in Review

Susquehanna Trust & Investment reduced its Pfizer (PFE) stake by 4% in Q2 2015, selling an estimated $537K and leaving 395,313 shares worth $12.6M. The position accounts for 2.75% of the portfolio, ranked #2.

Susquehanna Trust & Investment first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $15.7M in Q3 2013. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Susquehanna Trust & Investment held 395,313 shares of Pfizer worth $12.6M as of Q2 2015.
Susquehanna Trust & Investment sold 16,472 Pfizer shares in Q2 2015, an estimated $537K.
Pfizer made up 2.75% of Susquehanna Trust & Investment's portfolio in Q2 2015, its #2 holding.
Susquehanna Trust & Investment first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
Susquehanna Trust & Investment's Pfizer position peaked at $15.7M in Q3 2013.
1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Susquehanna Trust & Investment's 13F filing for Q2 2015, filed 24 Jul 2015.